Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Love my Roth, love my INO in my Roth.
New Seeking Alpha article out on ONCS and electroporation, no INO mention, but still good for the technology.
Nice Seeking Alpha article out today, will anyone notice?
If he did, he burned alot of friends and family.
Didn't mean to come off like a wise ass, and agree about the lucky and smart thing, not a champion out there that hasn't had a break or three along the way.
Sorry don't believe in spirits either, unless there is proof.
Like 86 proof, 100 proof, etc. Have a good night and a better day tomorrow for all longs.
Faith is belief in something for which there is no proof. Inovio is proving their science, otherwise they would not be lining up all of these vaccines for FDA approval. If you know what you have and you know that it works, you want to get it out there ahead of everybody else for as many indications as possible. They are looking to run the table.
With the method of delivery and the synthetic DNA, the ability to tweak the molecule and address new strains in days, they have potential to own the market in a few years. The first vaccine that makes it through the process virtually ensures everyone that follows will do the same.
LOL, regardless of the PPS and the shenanigans by the shorts, this company's position keeps strengthening. Might get some drift down in lack of news, but we might hold here too.
I added a bit a 1.47 today. But I plan to add even more when Kim hits the road for the dog and pony show.
Per the call SG&A expenses now down from $1.5 million per month to 1.0 million per month. Revenues tracking back over $15 million per quarter. All 40k per month saving from closing of NY facility. I expect net income to increase from 2 cents this quarter to 6 cents for 3q. I also expect PPS to run up to $1.50 before end of year.
But near term PPS might actually fall back because the 2q revs were down from 1q. If insiders do not buy, PPS could drop to 75 cents. If I am right that gives a chance to double up in less than 5 months.
Be honest here, how many of us were quietly swearing under our breath that we wished we had bought more shares at lower PPS when the stock lurched up to $3? Nothing has changed since then other than we may be given that opportunity.
I have a plan to add up to 100% of my current holdings as follows. 10% at my first determined level, 20% at the next lower level, 30% at the next lower level and 40% at the last potential lowest level. I really don't expect to see the last two levels hit, but if they are, I will buy.
Think along the same lines and thank your lucky stars for the second chance if it comes.
Probably so, right? I did sell some in the 30s last week but will probably hold the rest this time but like I said who knows. Some stocks I have a real feel for, (INO) others, no rhythm at all.
It's kind of like I should buy this stock in the 20s and sell in the 30s. Say any 20s and any 30s. Easy money, right? It seems obvious but I have failed to do it twice now anticipating a big breakout.
It protects her in the event of a buyout by a larger company with its own CFO.
They probably thought they timed it quite well considering I went from 1.48 - 1.50 down to 1.20 before making its big run.
It is not about anything more than market perception at this time and $ 500 million market cap was too rich. $250 million is probably more reasonable.
This company has huge potential but it does remain an early stage play. I love it and am holding a big chunk of what are now free shares to let ride. Regardless of where this stock PPS settles it is only a proxy for what investors believe the risk versus reward is at this time until tangible news is achieved.
The shorts and poorly informed sellers will use the earnings report as another excuse for a sell off. That is a joke, there is nothing to take from the report except that they were savvy enough to gather some cash from the spike without looking like they stuck it to investors.
In 5 years we will probably be a $68 or a 68 cent stock, grand slam or strikeout. I still believe in the former but am prepared for either scenario.
Man, I was going to put this one in the fridge for a while but I just might have to buy another 30 pack or two if they are on special next week. Oh well, never have too much on hand.
Revenue run going back up and expenses going way down!
Been a long time since we have seen black numbers from this company, maybe a sign of things to come.
Closed on a little down run. The wolves will probably make a run at the herd at the opening tomorrow to squeeze as much fear out of it as they can. After the first half hour we should begin to see the end of these guys as they will have moved this down around 50% in total. And we will begin to level into a market cap of 250 to 300 million until the news starts rolling in. And they will have moved on.
Do not get caught up in these debates about holding versus buying, traders versus long term holders, etc., it all means nothing. Your buy and sell decisions should be made well in advance of having to execute them.
If you are a holder none of these price changes affects your expectations unless you have ADHD. Read no further.
If you do want to trade the volatility, look at every big up and down moves this stock has made since it broke the 70s. Every end of a run, every end of a fall were characterized by an explosive change in PPS.
if you do want to trade and increase your holdings or profit potential, Train yourselves to do the opposite and you will win 9 out of 10 times. Don't worry about it running away, in those instances, in the absence of current facts, it will come back, unless it is trading dirty, which seldom really happens. Good luck.
If it does, lots of us will be loading up, the science has not changed, nor has the long term potential.
No such luck mmrich, but If you were hoping for cheaper shares this is your chance.
Always pays to have some dry powder to be able to add shares. None of us longs believe this is less that a billion dollar plus company, so these prices are a bargain if you are looking at longer term, and haven't "marginalized" yourself at higher levels. Hold fast!
Rebuilt my core at 1.85, prepared to double down on any further downdraft . I see a market cap of 300 mil as a bottom but irrationality rules here right now.
A good day to buy.
Thanks for the response, I like the prospects, bought it at 7.15 and sold at 7.65 , consider it again if it falls back to low 7s. Am concerned about how much of the success is priced in. Good luck.
Another good day! Would love to see continued and quiet upward movement will allow us to build a strong launch pad. I'd love a walk up to .40 before any real outside interest picks up.
Have to say that's a scary scenario. $9 on good news is not a lot, considering that bad news would probably drop it like a stone.
LOL, I will be trolling the big box retailers for a large cardboard box to live in at 1.50. Not because I will be poor, but because I will sell my house, my car, my truck and anything else I own to load up.
Bought back 25% of my core. Couldn't stay away for long.
They own delivery devices, no one owns electricity.
Not an expert on the delivery systems, INO licenses an older version of their EP to ONCS, but as CEO of ONCS is former INO exec, I'm sure he has a sufficient knowledge of it to see it as a viable delivery system for their use.
Think of electroporation as the jockey and the vaccines and medicines as the horses. INO has a lot more thoroughbreds in their stable. That doesn't diminish ONCS, just gives INO more shots at winners, and maybe a triple crown. But small stables produce winners too.
Usually with volume and volatility like this we see a huge influx of traders. While that always happens, I suspect this stock is getting a whole lot of institutional and retail investor support. That may minimize any potential retrenchment. It is looking good today, that blast to $3 yesterday was a last minute anomaly, so as far as I am concerned it is really just consolidating at its real close, which is excellent news for longs. Good luck.
I'm not a technicals investor by any stretch, but I have my own version of TA, I call it dirt bike TA. If the upward slope of a stock reaches an incline that a dirt bike could not navigate, absent of news, I sell. I expect it to fall below the price at which I sold. It works for me time and time again. If it doesn't work this time, so be it. I don't think we are at a point where this level of movement is sustainable. I think there has been an enormous inflow of traders that may cause a downdraft that will enable me to re-enter at a lower level. If I am wrong, I'm still holding a 320% gain in less than a month on my buys and sells. I still think this will be a $30 stock some day, so whether I am back in at $2.50 or 3.50 with a core position may be irrelevant. Good luck to you.
Those scumbags always hedge their calls. Here's another article that they released today:
http://beta.fool.com/usmananalyst/2013/08/05/alnylam-pharmaceuticals-gains-after-successful-cli/41508/?source=eogyholnk0000001
Read the last line under"Other gainers for the week "
They write one positive article and counter with a negative article so they are never wrong, and never right.
MrG, you would be better served to research this yourself. I sold the remainder of my shares today and will sweat bullets until I buy some back when I feel the risk reward rebalances.
No stock gets a $500 million market cap at such early stages without careful scrutiny and enormous potential. Think late 1990s. This could be Google or this could be Pets.com. I lean toward the former for a few reasons. The vaccines use no live virus and can be easily modified. Some possess cure as well as preventive properties. The likelihood of interactions and complications are minimized.
The science is advanced, the scientists are among the most respected in the world. The potential is real, and the investment community is just beginning to become aware of it. I have yet to see a professional (MD, PharmD, DNA expert) say anything but good things and many are very excited about the possibility. I am sure a great deal of new money here is from those sources.
I can't say whether it is overvalued right now in the face of this enormous potential that has yet to be realized. That is for you to decide. I can say whether I buy more at less than today's close or at a higher price, I will own some of this again very soon because the upside is realistically $30 per share higher and the downside is only $3. That's just my assessment. Good luck!
Motley Fools talking INO down today, must really want some cheaper shares. I have found them to be one of he most useless sources of information, it is the one consistency they can pride themselves on over the past 15 years.
And it is all in a Roth IRA. Sweet.
I've felt that reaching a market cap of $500 million or about $2.78 per share would be all the risk the market would take without partnership, further approvals. Might find out this week, heck might find out today!